Endoscopic balloon dilatation for pediatric subglottic stenosis: a meta-analysis of successful outcomes.
Autor: | Alamri AA; Otolaryngology head and neck surgery, Taibah University, Medina, Saudi Arabia. Dr.abdullah125@gmail.com., Alnefaie MN; Department of Otolaryngology Head and Neck Surgery, King Fahad Armed Forces Hospital, Medical Services of The Armed Forces, Jeddah, Saudi Arabia., Alsulami OA; Otolaryngology-Head and Neck Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia., Tonkal A; Department of Otolaryngology, Head and Neck Surgery, King Abdulaziz University, Jeddah, Saudi Arabia., Assiry MM; Pediatric Department, East Jeddah General Hospital, Jeddah, Saudi Arabia., Al-Khatib T; Department of Otolaryngology, Head and Neck Surgery, King Abdulaziz University, Jeddah, Saudi Arabia. |
---|---|
Jazyk: | angličtina |
Zdroj: | European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2024 Aug; Vol. 281 (8), pp. 3977-3984. Date of Electronic Publication: 2024 Apr 05. |
DOI: | 10.1007/s00405-024-08582-4 |
Abstrakt: | Objectives: The primary goal of this study was to systematically identify all relevant published articles on the use of primary endoscopic balloon dilation for the management of pediatric patients with subglottic stenosis, critically assess the technique's success, and determine which patients are the best candidates for the procedure. Methodology: This was a systematic review and meta-analysis that aimed to investigate the use and success rate of EBD for treating pediatric SGS. An electronic systematic literature search of three major databases, PubMed, EBSCO, and Web of Science&MEDLINE through Clarivate, was conducted to include the eligible articles. Results: A total of 14 unique studies were included in the final analysis, with 473 cases of pediatric SGS. The pooled success rate of EBD in treatment of pediatric SGS was 76% (k = 14 studies, 95% confidence interval [CI] = 0.65-0.86, P < 0.001, Q test for heterogeneity = 0.03, P < .001, I 2 = 91%). Conclusions: We reported a high success rate of EBD in treating pediatric SGS. The reported complications were uncommon, although they can be serious and life threatening. The intensity of SGS may be related to the likelihood of therapy failure. (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.) |
Databáze: | MEDLINE |
Externí odkaz: |